| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 12/28/2006 | US20060293326 2-Heteroaryl-imidazotriazinones and their use in the treatment of inflammatory or immune diseases |
| 12/28/2006 | US20060293297 Cyanofluoropyrrolidine derviative |
| 12/28/2006 | US20060293256 Remedy or preventive for kidney disease and method of diagnosing kidney disease |
| 12/28/2006 | US20060293252 such as 3-(4-Methoxy-phenyl)-1-[3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-thiophen-2-yl]-propan-1-one; for use as antidiabetics |
| 12/28/2006 | US20060293221 Mucosal repair by TFF2 peptides |
| 12/28/2006 | CA2633030A1 Intralesional treatment of psoriasis |
| 12/27/2006 | EP1736541A1 Novel galectin 9 modification protein and use thereof |
| 12/27/2006 | EP1736470A2 Pyrimidine derivatives as CB2 cannabinoid receptor modulators |
| 12/27/2006 | EP1736151A2 Pharmaceutical composition for the therapy of lower urinary tract symptoms |
| 12/27/2006 | EP1406876B1 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors |
| 12/27/2006 | EP1392276B1 Potentiation of therapeutic effects of polyunsaturated fatty acids |
| 12/27/2006 | EP1368317B1 Tryptase inhibitors |
| 12/27/2006 | EP1358209B1 Crystallization of igf-1 |
| 12/27/2006 | EP1332372B1 Net, a transcription factor of the tcf family, as regulator of angiogenic factor expression |
| 12/27/2006 | EP1299374B1 Novel non-psychotropic cannabinoids |
| 12/27/2006 | EP1284717B1 Formulation based on heparin, glycosaminoglycan or heparinoid, use of the formulation and the formulation base |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | CN1886423A Glycoisoforms of adiponectin and uses thereof |
| 12/27/2006 | CN1886386A Phenylene derivative having tetrazole ring or thiazolidinedione ring |
| 12/27/2006 | CN1886366A Cyclopentyl derivates |
| 12/27/2006 | CN1886141A T-type calcium channel inhibitor |
| 12/27/2006 | CN1883695A Medicine for treating functional renal failure and preparation method thereof |
| 12/27/2006 | CN1883694A Snow lotus preparation for treating prostate disease |
| 12/27/2006 | CN1883692A Calculi dissolving dan with climbing fern, chickens gizzard-membrane and curcuma root |
| 12/27/2006 | CN1883685A Nano Chinese medicinal preparation of 'An Gong Niu Huang Wan' and preparation method thereof |
| 12/27/2006 | CN1883666A Pharmaceutical composition for treating nephritis |
| 12/27/2006 | CN1883658A Kidney replenishing tablet with rhizome gymnadeniae |
| 12/27/2006 | CN1883612A Kidney-replenishing sperm-supplementing granule |
| 12/27/2006 | CN1883601A Chinese medicinal capsule for treating inflammation and method for preparing same |
| 12/27/2006 | CN1883570A Method for preparing compound pyrrosia leaf capsule |
| 12/27/2006 | CN1292001C Nucleus factor-kB p50 subunit antagonist peptide, preparation and application thereof |
| 12/27/2006 | CN1292000C Nucleus factor-kB p65 subunit combination peptide, preparation and application thereof |
| 12/27/2006 | CN1291988C Triazaspiro [5,5] undecane derivatrives and drugs containing the same as active ingredient |
| 12/27/2006 | CN1291986C Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions |
| 12/27/2006 | CN1291978C Novel crystal form of 5-hydroxy-1-methyl hydantoin |
| 12/27/2006 | CN1291748C Medicine for treating bed-wetting |
| 12/26/2006 | US7154001 Formate salt of O-desmethyl-venlafaxine |
| 12/26/2006 | US7153959 treatment of tumor necrosis factor mediated disorders; asthma; inflammatory bowel disease; arthritis |
| 12/26/2006 | US7153940 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 12/26/2006 | US7153873 E.g., 7-acetyl-5-tert-butylamino-6-phenyl-imidazo[2,1-b]-thiazol-7-ium chloride; treatment of pain, diarrhea, urinary incontinence, depression, and anxiety |
| 12/26/2006 | US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease |
| 12/26/2006 | US7153850 Lactam compounds and pharmaceutical use thereof |
| 12/26/2006 | US7153841 Conjugates with carriers; red shifted absorption; antiproliferative and antitumor agents; benign prostatic hyperplasia; diagnosis |
| 12/26/2006 | US7153833 Therapeutic uses of SMR1 peptides |
| 12/26/2006 | US7153678 Polynucleotides encoding the novel human phosphatase, RET31, and variants thereof |
| 12/26/2006 | US7153514 Use of botulinum toxin therapy for prostatic hyperplasia and related disorders |
| 12/21/2006 | WO2006135497A1 Aqueous crop protection formulations comprising asulam and synergistic herbicidal combinations thereof |
| 12/21/2006 | WO2006135080A1 Thienopyrimidine derivative |
| 12/21/2006 | WO2006134963A1 Agent for fibrous disease comprising oxaluric acid derivtive |
| 12/21/2006 | WO2006116169A3 Methods for modulating bladder function |
| 12/21/2006 | WO2006108686A3 Bnp agonists |
| 12/21/2006 | US20060287536 Phenyl-thiophene type vitamin d receptor modulators |
| 12/21/2006 | US20060287510 Crystallization of IGF-1 |
| 12/21/2006 | US20060287395 Pharmaceutical composition for the therapy of lower urinary tract symptoms |
| 12/21/2006 | US20060287380 To treat diseases of respiratory, urinary and gastrointestinal systems; highly selective; significant potency; (2R,2S)(1 alpha ,5 alpha ,6 alpha )-N-{-[4-(1,3-dioxo-1,3-dihydro-isoindol-2-yl)-butyl]-3-azabicyclo[3.1.0]hex-6-yl-methyl}-2-hydroxy-2-cyclopentyl-2-phenylacetamide |
| 12/21/2006 | US20060287367 Pyridoxamine for the treatment of diabetic kidney disease |
| 12/21/2006 | US20060287340 e.g. 5-(4-fluorophenyl)-N-[2-(1-methyl-2-oxo-1,7-diazaspiro[4,4]nonan-7-yl)-6-quinolinyl]-2-pyrimidinecarboxamide; melanin concentrating hormone receptor antagonist; central nervous system disorders, cardiovascular disorders and metabolic disorders |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |
| 12/21/2006 | US20060287268 Splice-region antisense composition and method |
| 12/21/2006 | US20060287235 Crystallization of IGF-1 |
| 12/21/2006 | US20060286150 Prevent menopause syndrome; therapy for skin aging; topical applying |
| 12/21/2006 | US20060286125 Immunomodulation; Yatapoxvirus polypeptide; multiple sclerosis, psoriasis, atopic dermatitis, type 1 insulin-dependent diabetes mellitus, dermatitis, Sjoigren's syndrome, encephalitis, Reiter's syndrome, psoriatic arthritis, progressive systemic sclerosis, primary biliary cirrhosis |
| 12/21/2006 | US20060286105 Tgf-beta antagonists combined with renin-angiotensin-aldosteron-system antagonists for treating renal insufficiency |
| 12/21/2006 | US20060286031 Modulators of tissue regeneration |
| 12/21/2006 | DE19843489B4 Benzoylguanidin-Abkömmlinge mit vorteilhaften Eigenschaften, Verfahren zu ihrer Herstellung und ihre Verwendung bei der Herstellung von Arzneimitteln, sowie diese enthaltende pharmazeutische Zubereitung Benzoylguanidine-derivatives having advantageous properties, to processes for their preparation and their use in the manufacture of medicinal products and pharmaceutical preparation containing them |
| 12/21/2006 | CA2611665A1 Aqueous crop protection formulations comprising asulam and synergistic herbicidal combinations thereof |
| 12/21/2006 | CA2610159A1 Methods to reduce oxalate concentration by administration of oxalate oxidase crystals |
| 12/20/2006 | EP1734133A2 Heparanase specific molecular probes and their use in research and medical applications |
| 12/20/2006 | EP1734122A2 APO-2 ligand |
| 12/20/2006 | EP1734040A1 Substituted quinazoline or pyridopyrimidine derivative |
| 12/20/2006 | EP1733736A2 Method of producing recombinant antibodies against tumours |
| 12/20/2006 | EP1733732A1 Insulin resistance improving agent |
| 12/20/2006 | EP1733728A2 Use of 2-alkoxyphenyl substituted imidazotriazinones as inhibitors of phosphodiesterase |
| 12/20/2006 | EP1401809B1 Tryptase inhibitors |
| 12/20/2006 | EP1357903B1 STABILIZED FORMULATIONS OF 6-HYDROXY-3-(4- 2-(PIPERIDIN-1-YL) ETHOXY|PHENOXY)-2-(4-METHOXYPHENYL) BENZO b|THIOPHENE AND SALTS THEREOF |
| 12/20/2006 | EP0836476B1 A COSMETIC COMPOSITION comprising the glycopropyl ester of retinoic acid FOR SKIN APPLICATIONS AND PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF skin diseases, TUMOROUS CELLS, BLADDER OR NERVE DISORDERS |
| 12/20/2006 | CN1879886A Sodium acetylide/ soybean separation protein commixed gel granule preparation method |
| 12/20/2006 | CN1879834A A medicinal liquor for treating spleen kidney both deficiency type hematuria and method for preparing same |
| 12/20/2006 | CN1879829A Blood circutlation-activating, kidney-replenishing, toxicant-expelling, weight-reducing capsule and process for preparing same |
| 12/20/2006 | CN1879826A A medicinal liquor for treating heart heat excessive type hematuria and method for preparing same |
| 12/20/2006 | CN1879825A A medicinal liquor for treating lower jiao heat accumulation type hematuria and method for preparing same |
| 12/20/2006 | CN1879823A A medicinal liquor for treating kidney-yin deficiency type hematuria and method for preparing same |
| 12/20/2006 | CN1879802A Nutritious Chinese medicinal product for replenishing liver and kidney, resisting senility, decreasing blood fat, blood sugar and blood pressure and method for preparing same |
| 12/20/2006 | CN1879770A A medicinal liquor for treating liver gallbladder damp-heat type hematuria and preparation method thereof |
| 12/20/2006 | CN1879763A A Chinese medicinal composition for treating prostatitis |
| 12/20/2006 | CN1879756A Quality control method of kidney-replenishing blood-nourishing soft capsule |
| 12/20/2006 | CN1879751A Medicine for treating enuresis and preparation method thereof |
| 12/20/2006 | CN1879729A A medicinal liquor for treating bladder damp-heat type hematuria and preparation method thereof |
| 12/20/2006 | CN1879630A Pharmaceutical compositions and uses for androst-5-ene-3 beta,17 beta-diol |
| 12/20/2006 | CN1879629A Estrogen replacement therapy |
| 12/20/2006 | CN1290848C Beta-amino tetrahydroimidazo (1,2-a) pyrazines and ahydrotrioazolo (4,3-a) pyrazines as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 12/20/2006 | CN1290833C N- ((3-oxo2, 3-dihydro-1H-isoindol-1-yl) acetyl) guanidine derivatives as NHE-1 inhibitors for the treatment of infarction and angina pectoris |
| 12/20/2006 | CN1290519C Effective part extract of Chinese medicine drynaria rhizome and its extracting method |
| 12/20/2006 | CN1290515C Poly(allylamine hydrochloride) with low salt content |
| 12/19/2006 | US7151169 For therapy of fibrosis, immune responses and tumor progression, asthma |
| 12/19/2006 | US7151118 N-(6-Methyl-4'-{[3-(4-methylpiperazin-1-yl)propylamino]carbonyl}-1,1'-biphenyl-3-yl)-2-pyrrolidin-1-ylisonicotinamide; enzyme inhibitors for the treatment of certain diseases and conditions; chemical synthesis |
| 12/19/2006 | US7151101 For prevention/treatment of cancer, inflammatory diseases, autoimmune diseases, destructive bone disorders, proliferative disorders, infectious diseases, viral diseases and neurodegenerative diseases |
| 12/19/2006 | US7151098 Glutamate receptor antagonists |
| 12/19/2006 | US7150986 Adhesion to mucous membranes; cell proliferation; prevention, therapy of digestion diseases |
| 12/14/2006 | WO2006132442A1 Vitamin d-like compound |